KRAS and cancer: In addition, it allows for the abrogation of oncogenic Kras expression at various stages of cancer development and thus the study of the dependence of developing lesions and cancer on mutant Kras. Also, this system can be employed to investigate carcinogenesis in the context of tumor suppressor inactivation or additional oncogene activation.